Highly Efficient Far-Red/NIR-Absorbing Neutral Ir(III) Complex Micelles for Potent Photodynamic/Photothermal Therapy

© 2021 Wiley-VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 32 vom: 30. Aug., Seite e2100795
Auteur principal: Liu, Bingqing (Auteur)
Autres auteurs: Jiao, Jian, Xu, Wan, Zhang, Miya, Cui, Peng, Guo, Zhengqing, Deng, Yibin, Chen, Huabing, Sun, Wenfang
Format: Article en ligne
Langue:English
Publié: 2021
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article Ir(III) complexes nanomedicine photosensitizers phototherapy tumor ablation 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene Boron Compounds Coordination Complexes Micelles plus... Singlet Oxygen 17778-80-2 Iridium 44448S9773
LEADER 01000caa a22002652c 4500
001 NLM327659394
003 DE-627
005 20250302022000.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202100795  |2 doi 
028 5 2 |a pubmed25n1092.xml 
035 |a (DE-627)NLM327659394 
035 |a (NLM)34219286 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Liu, Bingqing  |e verfasserin  |4 aut 
245 1 0 |a Highly Efficient Far-Red/NIR-Absorbing Neutral Ir(III) Complex Micelles for Potent Photodynamic/Photothermal Therapy 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 19.01.2022 
500 |a Date Revised 19.01.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2021 Wiley-VCH GmbH. 
520 |a A critical issue in photodynamic therapy (PDT) is inadequate reactive oxygen species (ROS) generation in tumors, causing inevitable survival of tumor cells that usually results in tumor recurrence and metastasis. Existing photosensitizers frequently suffer from relatively low light-to-ROS conversion efficiency with far-red/near-infrared (NIR) light excitation due to low-lying excited states that lead to rapid non-radiative decays. Here, a neutral Ir(III) complex bearing distyryl boron dipyrromethene (BODIPY-Ir) is reported to efficiently produce both ROS and hyperthermia upon far-red light activation for potentiating in vivo tumor suppression through micellization of BODIPY-Ir to form "Micelle-Ir". BODIPY-Ir absorbs strongly at 550-750 nm with a band maximum at 685 nm, and possesses a long-lived triplet excited state with sufficient non-radiative decays. Upon micellization, BODIPY-Ir forms J-type aggregates within Micelle-Ir, which boosts both singlet oxygen generation and the photothermal effect through the high molar extinction coefficient and amplification of light-to-ROS/heat conversion, causing severe cell apoptosis. Bifunctional Micelle-Ir that accumulates in tumors completely destroys orthotopic 4T1 breast tumors via synergistic PDT/photothermal therapy (PTT) damage under light irradiation, and enables remarkable suppression of metastatic nodules in the lungs, together without significant dark cytotoxicity. The present study offers an emerging approach to develop far-red/NIR photosensitizers toward potent cancer therapy 
650 4 |a Journal Article 
650 4 |a Ir(III) complexes 
650 4 |a nanomedicine 
650 4 |a photosensitizers 
650 4 |a phototherapy 
650 4 |a tumor ablation 
650 7 |a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene  |2 NLM 
650 7 |a Boron Compounds  |2 NLM 
650 7 |a Coordination Complexes  |2 NLM 
650 7 |a Micelles  |2 NLM 
650 7 |a Singlet Oxygen  |2 NLM 
650 7 |a 17778-80-2  |2 NLM 
650 7 |a Iridium  |2 NLM 
650 7 |a 44448S9773  |2 NLM 
700 1 |a Jiao, Jian  |e verfasserin  |4 aut 
700 1 |a Xu, Wan  |e verfasserin  |4 aut 
700 1 |a Zhang, Miya  |e verfasserin  |4 aut 
700 1 |a Cui, Peng  |e verfasserin  |4 aut 
700 1 |a Guo, Zhengqing  |e verfasserin  |4 aut 
700 1 |a Deng, Yibin  |e verfasserin  |4 aut 
700 1 |a Chen, Huabing  |e verfasserin  |4 aut 
700 1 |a Sun, Wenfang  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 33(2021), 32 vom: 30. Aug., Seite e2100795  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnas 
773 1 8 |g volume:33  |g year:2021  |g number:32  |g day:30  |g month:08  |g pages:e2100795 
856 4 0 |u http://dx.doi.org/10.1002/adma.202100795  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 33  |j 2021  |e 32  |b 30  |c 08  |h e2100795